Advancements in Tissue Engineering, Smart Buildings, Drug Delivery, Surgical Devices, and Liver-on-a-chip Platform

USD 250.00

* Required Fields

USD 250.00

PAY BY INVOICE

Be the first to review this product

This edition of the Inside R&D TechVision Opportunity Engine (TOE) depicts the current landscape and the new trends in tissue engineering, drug delivery, surgical devices, and liver-on-a-chip platform. The TOE also focuses on smart windows and sustainability in buildings.Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all technology areas. We provide intelligence and insights on innovations spanning a wide variety of industry areas, including automation, electronics, sensors, information and communication technologies, manufacturing, health, wellness, medical devices, pharma, biotechnology, materials, coatings, renewable fuels, automotiv

Table of Contents

Advancements in Tissue Engineering, Smart Buildings, Drug Delivery, Surgical Devices, and Liver-on-a-chip PlatformInnovations in Tissue Engineering, Smart Buildings, Drug Delivery, Surgical Devices, and Liver-on-a-chip PlatformGrowing Hydrogel Structures for Tissue EngineeringModifying Permeability of Light into Buildings Through Circulating FluidsDNA Robots for Targeted Drug Delivery and Cancer TherapyEnzymatic Scalpel for Incision-less Surgeries3D Microfluidic Liver-on-a-chip Platform




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.